Literature DB >> 30170106

Integrated prediction and decision models are valuable in informing personalized decision making.

Tim M Govers1, Maroeska M Rovers2, Marieke T Brands3, Emilie A C Dronkers4, Robert J Baatenburg de Jong4, Matthias A W Merkx3, Robert P Takes5, Janneke P C Grutters2.   

Abstract

OBJECTIVES: To show how prediction models can be incorporated into decision models, to allow for personalized decisions, and to assess the value of this approach using the management of the neck in early-stage oral cavity squamous cell carcinoma as an example. STUDY DESIGN AND
SETTING: In a decision model, three approaches were compared: a "population-based" approach in which patients undergo the strategy that is optimal for the population; a "perfectly predicted" approach, in which each patient receives the optimal strategy for that specific patient; and a "prediction model" approach in which each patient receives the strategy that is optimal based on prediction models. The average differences in costs and quality-adjusted life years (QALYs) for the population between these approaches were studied.
RESULTS: The population-based approach resulted on average in 4.9158 QALYs with €8,675 in costs, per patient. The perfectly predicted approach yielded 0.21 more QALYs and saved €1,024 per patient. The prediction model approach yielded 0.0014 more QALYs and saved €152 per patient compared with the population-based approach.
CONCLUSION: The perfectly predicted approach shows that personalized care is worthwhile. However, current prediction models in the field of oral cavity squamous cell carcinoma have limited value. Incorporating prediction models into decision models appears to be a valuable method to assess the value of personalized decision making.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cost-effectiveness; Decision modeling; Head and neck neoplasms; Individualized medicine; Lymph nodes; Prediction rule

Mesh:

Year:  2018        PMID: 30170106     DOI: 10.1016/j.jclinepi.2018.08.016

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  4 in total

Review 1.  Economic evaluations of big data analytics for clinical decision-making: a scoping review.

Authors:  Lytske Bakker; Jos Aarts; Carin Uyl-de Groot; William Redekop
Journal:  J Am Med Inform Assoc       Date:  2020-07-01       Impact factor: 4.497

Review 2.  Novel Diagnostic Approaches for Assessment of the Clinically Negative Neck in Head and Neck Cancer Patients.

Authors:  Daphne A J J Driessen; Tim Dijkema; Willem L J Weijs; Robert P Takes; Sjoert A H Pegge; Patrik Zámecnik; Adriana C H van Engen-van Grunsven; Tom W J Scheenen; Johannes H A M Kaanders
Journal:  Front Oncol       Date:  2021-02-05       Impact factor: 6.244

Review 3.  Towards early and broad evaluation of innovative surgical devices: integrating evidence synthesis, stakeholder involvement, and health economic modeling into the clinical research stages of the IDEAL framework.

Authors:  Mirre Scholte; Kas Woudstra; Janneke P C Grutters; Gerjon Hannink; Marcia Tummers; Rob P B Reuzel; Maroeska M Rovers
Journal:  BMJ Surg Interv Health Technol       Date:  2022-09-02

Review 4.  Value and Quality of Care in Head and Neck Oncology.

Authors:  Robert P Takes; Gyorgy B Halmos; John A Ridge; Paolo Bossi; Matthias A W Merkx; Alessandra Rinaldo; Alvaro Sanabria; Ludi E Smeele; Antti A Mäkitie; Alfio Ferlito
Journal:  Curr Oncol Rep       Date:  2020-07-10       Impact factor: 5.075

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.